Dose-response effects of selective serotonin reuptake inhibitor monotherapy for the treatment of depression: systematic review of reviews and meta-narrative synthesis

Keyphrases

• Acute Phase 16%
• Adult Age 16%
• Adverse Drug Effects 50%
• Adverse Effects 16%
• Citalopram 16%
• Clinical Practice Guidelines 16%
• Cochrane 16%
• Cochrane Collaboration 16%
• Community Pharmacists 16%
• Daily Dose 50%
• Degree Heterogeneity 16%
• Depression Treatment 100%
• Dose Effect 100%
• Dropout 33%
• Drug Treatment 16%
• Early Treatment Discontinuation 16%
• Embase 16%
• Escitalopram 16%
• Evaluation Method 16%
• Flat Dose 16%
• Fluoxetine 16%
• High Dropout Rate 16%
• Inclusion Criteria 33%
• MEDLINE 16%
• Methodological Diversity 16%
• Monotherapy 100%
• Narrative Synthesis 100%
• Nausea 16%
• Paroxetine 16%
• Prescribers 16%
• PsycINFO 16%
• Review Meetings 16%
• Risk of Bias 33%
• Scopus 16%
• Selective Serotonin Reuptake Inhibitors 100%
• Sertraline 16%
• Sexual Dysfunction 16%
• Study Review 16%
• Synthetic Approaches 16%
• Systematic Review of Reviews 100%
• Systematic Review Tools 16%
• Tolerability 66%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Drug Reaction 25%
• Adverse Effect of Drug 12%
• Adverse Event 12%
• Citalopram 12%
• Escitalopram 12%
• Fluoxetine 12%
• Monotherapy 100%
• Nausea 12%
• Paroxetine 12%
• Pharmacotherapy 12%
• Selective Serotonin Reuptake Inhibitor 100%
• Sertraline 12%
• Tolerability 50%